Overall age-adjusted mortality rates have fallen, but the poorest parts of the world aren’t sharing in the benefits.

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

Foldax has revealed one-year outcomes from the India Clinical Trial of the TRIA mitral valve. Presented at the Cardiovascular ...

"Preeclampsia is a blood pressure condition that occurs either at the end of or just after a pregnancy," Dr. Priya Freaney, ...

What researchers did observe by year's end, in terms of clinical events in the 67 patients with symptomatic moderate-to-severe or severe mitral valve disease, were a few cases of ...

After days of hearing the postpartum heaviness in her chest was anxiety, she began coughing up blood, and knew it was ...

Doctors were able to resuscitate him. Then, they got to work trying to figure out what was wrong. The man told them that for ...

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

For more information on the TRIA Mitral Valve and Foldax’s commitment to revolutionizing heart valve care, visit www.Foldax.com. MEDIA CONTACT: Michelle McAdam, Chronic Communications, Inc.

Detailed price information for Align Technology (ALGN-Q) from The Globe and Mail including charting and trades.